Article(id=1326652155508928771, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652135099445330, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.09.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1732636800000, receivedDateStr=2024-11-27, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228121877, onlineDateStr=2026-11-09, pubDate=1757433600000, pubDateStr=2025-09-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228121877, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228121877, creator=13701087609, updateTime=1794228121877, updator=13701087609, issue=Issue{id=1326652135099445330, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='9', pageStart='869', pageEnd='998', issueExtLink='null', onlineDate='null', pubDate='1757433600000', pubDateStr='2025-09-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228117011, creator='13701087609', updateTime=1794272950571, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326840181111501690, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652135099445330, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326840181111501691, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652135099445330, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=878, endPage=883, ext={EN=ArticleExt(id=1326652157304090885, articleId=1326652155508928771, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=A personalized treatment direction for melanoma: vaccine, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Tumor vaccine therapy activates and enhances the body's natural immune response against tumor cells by utilizing specific antigens present in the tumor microenvironment. These antigens are specifically expressed by tumor-specific proteins only in tumor cells, are not affected by central immune tolerance, and have both high immunogenicity and tumor specificity, making them ideal targets for treatment and a promising direction for personalized immunotherapy. Although the research and application of immunotherapy in malignant melanoma has a long history and has achieved significant results, there are still considerable limitations. This article reviewed the types and mechanisms of tumor vaccines related to malignant melanoma and analyze the effectiveness and limitations of each type of vaccine.

, authors=Bei GUOa, Fei WUb, *, Yan QIANGa, authorsList=Bei GUO, Fei WU, Yan QIANG, authorCompany=null, correspAuthors=Fei WU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326652157559943430, articleId=1326652155508928771, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=恶性黑色素瘤个体化治疗方向:肿瘤疫苗, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

肿瘤疫苗疗法是通过利用肿瘤微环境中存在的特定抗原,激活并增强人体免疫系统对肿瘤细胞的自然免疫反应。这类抗原由肿瘤特异性蛋白仅在肿瘤细胞中特异表达,不受中枢免疫耐受影响,兼具高免疫原性及肿瘤特异性,成为治疗的理想靶点和个性化免疫治疗方向。尽管免疫疗法在恶性黑色素瘤中的研究与应用历史悠久,也取得了显著成果,但仍存在相当大的局限性。该文将对恶性黑色素瘤相关的肿瘤疫苗类型及其作用机制进行综述,分析各类型疫苗的有效性和局限性。

, authors=郭蓓a, 吴飞b, *, 强燕a, authorsList=郭蓓, 吴飞, 强燕, authorCompany=null, correspAuthors=吴飞, authorNote=

郭蓓,主管护师,研究方向:皮肤护理。

, correspAuthorsNote=
吴飞,主治医师,研究方向:皮肤病理。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=LYrfaZYWhC/dPJzfGm9wtw==, magXml=B9BTWhbR7iV5zcQqtysY9g==, pdfUrl=null, pdf=3xQCt3Sx7LzSAQ6N/rRdwg==, pdfFileSize=976331, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=uIrQg2xuDn92Pmb8AVLSLg==, mapNumber=null, fund=null)}, authors=[Author(id=1326652157966790927, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652158046482705, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, authorId=1326652157966790927, language=EN, stringName=Bei GUO, firstName=Bei, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=a, address=a.Department of Dermatology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652158109397266, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, authorId=1326652157966790927, language=CN, stringName=郭蓓, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=a, address=a.上海同济大学附属皮肤病医院皮肤科,上海 200443, bio={"content":"

郭蓓,主管护师,研究方向:皮肤护理。

"}, bioImg=null, bioContent=

郭蓓,主管护师,研究方向:皮肤护理。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652157778047239, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, xref=a., ext=[AuthorCompanyExt(id=1326652157786435848, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157778047239, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.Department of Dermatology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China), AuthorCompanyExt(id=1326652157794824457, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157778047239, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.上海同济大学附属皮肤病医院皮肤科,上海 200443)])]), Author(id=1326652158189089044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652158281363734, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, authorId=1326652158189089044, language=EN, stringName=Fei WU, firstName=Fei, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=b, *, address=b.Department of Pathology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652158369444119, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, authorId=1326652158189089044, language=CN, stringName=吴飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=b, *, address=b.上海同济大学附属皮肤病医院病理科,上海 200443, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652157853544715, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, xref=b., ext=[AuthorCompanyExt(id=1326652157861933324, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157853544715, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.Department of Pathology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China), AuthorCompanyExt(id=1326652157887099149, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157853544715, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.上海同济大学附属皮肤病医院病理科,上海 200443)])]), Author(id=1326652158436552985, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652158495273243, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, authorId=1326652158436552985, language=EN, stringName=Yan QIANG, firstName=Yan, middleName=null, lastName=QIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=a, address=a.Department of Dermatology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652158553993500, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, authorId=1326652158436552985, language=CN, stringName=强燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=a, address=a.上海同济大学附属皮肤病医院皮肤科,上海 200443, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652157778047239, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, xref=a., ext=[AuthorCompanyExt(id=1326652157786435848, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157778047239, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.Department of Dermatology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China), AuthorCompanyExt(id=1326652157794824457, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157778047239, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.上海同济大学附属皮肤病医院皮肤科,上海 200443)])])], keywords=[Keyword(id=1326652158642073885, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, language=EN, orderNo=1, keyword=malignant melanoma), Keyword(id=1326652158709182750, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, language=EN, orderNo=2, keyword=immunotherapy), Keyword(id=1326652158772097311, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, language=EN, orderNo=3, keyword=tumor vaccine), Keyword(id=1326652158835011872, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, language=CN, orderNo=1, keyword=恶性黑色素瘤), Keyword(id=1326652158885343521, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, language=CN, orderNo=2, keyword=免疫治疗), Keyword(id=1326652158952452386, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, language=CN, orderNo=3, keyword=肿瘤疫苗)], refs=[Reference(id=1326652159027949859, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=LONG GV, SWETTER SM, MENZIES AM, et al. Cutaneous melanoma[J]. Lancet, 2023, 402(10400): 485-502., articleTitle=null, refAbstract=null), Reference(id=1326652159090864420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=WASEH S, LEE JB. Advances in melanoma: epidemiology, diagnosis, and prognosis[J]. Front Med(Lausanne), 2023,10: 1268479., articleTitle=null, refAbstract=null), Reference(id=1326652159157973285, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=SAXENA M, VAN DER BURG SH, MELIEF CJM, et al. Therapeutic cancer vaccines[J]. Nat Rev Cancer, 2021,21(6): 360-378., articleTitle=null, refAbstract=null), Reference(id=1326652159220887846, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=JHUNJHUNWALA S, HAMMER C, DELAMARRE L. Antigen presentation in cancer: Insights into tumour immunogenicity and immune evasion[J]. Nat Rev Cancer, 2021, 21(5): 298-312., articleTitle=null, refAbstract=null), Reference(id=1326652159275413799, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=RUHLAND MK, ROBERTS EW, CAI E, et al. Visualizing synaptic transfer of tumor antigens among dendritic cells[J]. Cancer Cell, 2020, 37(6): 786-799., articleTitle=null, refAbstract=null), Reference(id=1326652159359299880, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=GILES JR, GLOBIG AM, KAECH SM, et al. CD8+ T cells in the cancer-immunity cycle[J]. Immunity, 2023, 56(10):2231-2253., articleTitle=null, refAbstract=null), Reference(id=1326652159426408745, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=SPEISER DE, CHIJIOKE O, SCHAEUBLE K, et al. CD4+ T cells in cancer[J]. Nat Cancer, 2023, 4(3): 317-329., articleTitle=null, refAbstract=null), Reference(id=1326652159497711914, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=KALARIYA M, GANTA S, AMIJI M. Multi-compartmental vaccine delivery system for enhanced immune response to GP100 peptide antigen in melanoma immunotherapy[J]. Pharm Res, 2012, 29(12): 3393-3403., articleTitle=null, refAbstract=null), Reference(id=1326652159573209387, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Al FAYEZ N, NASSAR MS, ALSHEHRI AA, et al. Recent advancement in mRNA vaccine development and applications[J]. Pharmaceutics, 2023, 15(7): 1972., articleTitle=null, refAbstract=null), Reference(id=1326652159640318252, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE KW, YAM JWP, MAO X. Dendritic cell vaccines: a shift from conventional approach to new generations[J]. Cells, 2023, 12(17): 2147., articleTitle=null, refAbstract=null), Reference(id=1326652159703232813, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=CHI H, HAO Y, WANG X, et al. A therapeutic whole-tumor-cell vaccine covalently conjugated with a TLR7 agonist[J]. Cells, 2022, 11(13): 1986., articleTitle=null, refAbstract=null), Reference(id=1326652159761953070, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=PENG M, MO YZ, WANG Y, et al. Neoantigen vaccine:an emerging tumor immunotherapy[J]. Mol Cancer, 2019,18(1): 128., articleTitle=null, refAbstract=null), Reference(id=1326652159829061935, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=MAURER DM, BUTTERFIELD LH, VUJANOVIC L. Melanoma vaccines: clinical status and immune endpoints[J]. Melanoma Res, 2019, 29(2): 109-118., articleTitle=null, refAbstract=null), Reference(id=1326652159900365104, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=SHEIKHI A, JAFARZADEH A, KOKHAEI P, et al. Whole tumor cell vaccine adjuvants: comparing IL-12 to IL-2 and IL-15[J]. Iran J Immunol, 2016, 13(3): 148-166., articleTitle=null, refAbstract=null), Reference(id=1326652159954891057, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=KAN B, YANG L, WEN YJ, et al. Irradiated VEGF164-modified tumor cell vaccine protectedmice from the parental tumor challenge[J]. Anticancer Drugs, 2017, 28(2): 197-205., articleTitle=null, refAbstract=null), Reference(id=1326652160021999922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=MENG JQ, LV YL, BAO WE, et al. Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation[J]. Nat Commun, 2023, 14(1): 4505., articleTitle=null, refAbstract=null), Reference(id=1326652161708110132, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=GUO LN, DING JS, ZHOU WH. Converting bacteria into autologous tumor vaccine via surface biomineralization of calcium carbonate for enhanced immunotherapy[J]. Acta Pharm Sin B, 2023, 13(12): 5074-5090., articleTitle=null, refAbstract=null), Reference(id=1326652161779413301, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=REZAEI T, DAVOUDIAN E, KHALILI S, et al. Strategies in DNA vaccine for melanoma cancer[J]. Pigment Cell Melanoma Res, 2021, 34(5): 869-891., articleTitle=null, refAbstract=null), Reference(id=1326652161850716470, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=COLLURU VT, JOHNSON LE, OLSON BM, et al. Preclinical and clinical development of DNA vaccines for prostate cancer[J]. Urol Oncol, 2016, 34(4): 193-204., articleTitle=null, refAbstract=null), Reference(id=1326652161926213943, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=PELLIN MA. The use of oncept melanoma vaccine in veterinary patients: a review of the literature[J]. Vet Sci, 2022, 9(11): 597., articleTitle=null, refAbstract=null), Reference(id=1326652161989128504, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=DUPERRET EK, LIU SJ, PAIK M, et al. A designer cross-reactive DNA immunotherapeutic vaccine that targets multiple MAGE-A family members simultaneously for cancer therapy[J]. Clin Cancer Res, 2018, 24(23): 6015-6027., articleTitle=null, refAbstract=null), Reference(id=1326652162047848761, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=SAHIN U, OEHM P, DERHOVANESSIAN E, et al. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma[J]. Nature, 2020, 585(7823): 107-112., articleTitle=null, refAbstract=null), Reference(id=1326652162114957626, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=BORDON Y. An RNA vaccine for advanced melanoma[J]. Nat Rev Drug Discov, 2020, 19(10): 671., articleTitle=null, refAbstract=null), Reference(id=1326652162173677883, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=WEBER JS, CARLINO MS, KHATTAK A, et al. Individualised neoantigen therapy mRNA-4157(V940)plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma(KEYNOTE-942): a randomised, phase 2b study[J]. Lancet, 2024, 403(10427): 632-644., articleTitle=null, refAbstract=null), Reference(id=1326652162253369660, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU WS, TANG HC, LI LF, et al . Peptide-based therapeutic cancer vaccine: current trends in clinical application[J]. Cell Prolif, 2021, 54(5): e13025., articleTitle=null, refAbstract=null), Reference(id=1326652162333061437, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=LI WH, SU JY, LI YM. Rational design of T-cell- and B-cell-based therapeutic cancer vaccines[J]. Acc Chem Res, 2022,55(18): 2660-2671., articleTitle=null, refAbstract=null), Reference(id=1326652162429530430, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=ESFANDIARY A, GHAFOURI-FARD S. MAGE-A3:an immunogenic target used in clinical practice[J]. Immunotherapy, 2015, 7(6): 683-704., articleTitle=null, refAbstract=null), Reference(id=1326652162588913983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=SCHWARTZENTRUBER DJ, LAWSON DH, RICHARDS JM, et al. GP100 peptide vaccine and interleukin-2 in patients with advanced melanoma[J]. N Engl J Med, 2011, 364(22):2119-2127., articleTitle=null, refAbstract=null), Reference(id=1326652162668605760, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=HODI FS, O'DAY SJ, MCDERMOTT DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma[J]. N Engl J Med, 2010, 363(8): 711-723., articleTitle=null, refAbstract=null), Reference(id=1326652162744103233, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=ELWAKEEL A, BRIDGEWATER HE, BENNETT J. Unlocking dendritic cell-based vaccine efficacy through genetic modulation-how soon is now?[J]. Genes(Basel), 2023, 14(12): 2118., articleTitle=null, refAbstract=null), Reference(id=1326652162802823490, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=ADAMIK J, MUNSON PV, MAURER DM, et al. Immunometabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients[J]. Nat Commun, 2023, 14(1): 7211., articleTitle=null, refAbstract=null), Reference(id=1326652162886709571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=FARHOOD B, NAJAFI M, MORTEZAEE K. CD8+cytotoxic T lymphocytes in cancer immunotherapy: a review[J]. J Cell Physiol, 2019, 234(6): 8509-8521., articleTitle=null, refAbstract=null), Reference(id=1326652162945429828, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG RH, ZHU TC, HOU BZ, et al. An iPSC-derived exosome-pulsed dendritic cell vaccine boosts antitumor immunity in melanoma[J]. Mol Ther, 2023, 31(8): 2376-2390., articleTitle=null, refAbstract=null), Reference(id=1326652163020927301, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=XUE L, ZHANG HY, ZHENG XM, et al. Treatment of melanoma with dendritic cell vaccines and immune checkpoint inhibitors: a mathematical modeling study[J]. J Theor Biol, 2023, 568(19): 111489., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1326652157778047239, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, xref=a., ext=[AuthorCompanyExt(id=1326652157786435848, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157778047239, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.Department of Dermatology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China), AuthorCompanyExt(id=1326652157794824457, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157778047239, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.上海同济大学附属皮肤病医院皮肤科,上海 200443)]), AuthorCompany(id=1326652157853544715, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, xref=b., ext=[AuthorCompanyExt(id=1326652157861933324, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157853544715, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.Department of Pathology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China), AuthorCompanyExt(id=1326652157887099149, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157853544715, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.上海同济大学附属皮肤病医院病理科,上海 200443)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.09.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.09.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.09.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.09.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1757433600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
恶性黑色素瘤个体化治疗方向:肿瘤疫苗
郭蓓 a , 吴飞 b, * , 强燕 a
世界临床药物 | 医药专论 2025,46(9): 878-883
收起
收藏切换
世界临床药物 |医药专论 2025 , 46 (9) : 878 -883
恶性黑色素瘤个体化治疗方向:肿瘤疫苗
全屏
[Author(id=1326652157966790927, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652158046482705, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, authorId=1326652157966790927, language=EN, stringName=Bei GUO, firstName=Bei, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=a, address=a.Department of Dermatology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652158109397266, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, authorId=1326652157966790927, language=CN, stringName=郭蓓, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=a, address=a.上海同济大学附属皮肤病医院皮肤科,上海 200443, bio={"content":"

郭蓓,主管护师,研究方向:皮肤护理。

"}, bioImg=null, bioContent=

郭蓓,主管护师,研究方向:皮肤护理。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652157778047239, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, xref=a., ext=[AuthorCompanyExt(id=1326652157786435848, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157778047239, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.Department of Dermatology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China), AuthorCompanyExt(id=1326652157794824457, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157778047239, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.上海同济大学附属皮肤病医院皮肤科,上海 200443)])]), Author(id=1326652158189089044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652158281363734, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, authorId=1326652158189089044, language=EN, stringName=Fei WU, firstName=Fei, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=b, *, address=b.Department of Pathology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652158369444119, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, authorId=1326652158189089044, language=CN, stringName=吴飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=b, *, address=b.上海同济大学附属皮肤病医院病理科,上海 200443, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652157853544715, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, xref=b., ext=[AuthorCompanyExt(id=1326652157861933324, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157853544715, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.Department of Pathology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China), AuthorCompanyExt(id=1326652157887099149, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157853544715, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.上海同济大学附属皮肤病医院病理科,上海 200443)])]), Author(id=1326652158436552985, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652158495273243, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, authorId=1326652158436552985, language=EN, stringName=Yan QIANG, firstName=Yan, middleName=null, lastName=QIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=a, address=a.Department of Dermatology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652158553993500, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, authorId=1326652158436552985, language=CN, stringName=强燕, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=a, address=a.上海同济大学附属皮肤病医院皮肤科,上海 200443, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652157778047239, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, xref=a., ext=[AuthorCompanyExt(id=1326652157786435848, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157778047239, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.Department of Dermatology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China), AuthorCompanyExt(id=1326652157794824457, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652155508928771, companyId=1326652157778047239, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.上海同济大学附属皮肤病医院皮肤科,上海 200443)])])]
郭蓓a, 吴飞b, *, 强燕a
作者信息
  • a.上海同济大学附属皮肤病医院皮肤科,上海 200443
  • b.上海同济大学附属皮肤病医院病理科,上海 200443
通讯作者:
吴飞,主治医师,研究方向:皮肤病理。
作者简介:

郭蓓,主管护师,研究方向:皮肤护理。

A personalized treatment direction for melanoma: vaccine
Bei GUOa, Fei WUb, *, Yan QIANGa
Affiliations
  • a.Department of Dermatology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China
  • b.Department of Pathology, Shanghai Skin Disease Hospital Affiliated to Shanghai Tongji University, Shanghai 200443, China
出版时间: 2025-09-10 doi: 10.13683/j.wph.2025.09.002
文章导航
收藏切换

肿瘤疫苗疗法是通过利用肿瘤微环境中存在的特定抗原,激活并增强人体免疫系统对肿瘤细胞的自然免疫反应。这类抗原由肿瘤特异性蛋白仅在肿瘤细胞中特异表达,不受中枢免疫耐受影响,兼具高免疫原性及肿瘤特异性,成为治疗的理想靶点和个性化免疫治疗方向。尽管免疫疗法在恶性黑色素瘤中的研究与应用历史悠久,也取得了显著成果,但仍存在相当大的局限性。该文将对恶性黑色素瘤相关的肿瘤疫苗类型及其作用机制进行综述,分析各类型疫苗的有效性和局限性。

恶性黑色素瘤  /  免疫治疗  /  肿瘤疫苗

Tumor vaccine therapy activates and enhances the body's natural immune response against tumor cells by utilizing specific antigens present in the tumor microenvironment. These antigens are specifically expressed by tumor-specific proteins only in tumor cells, are not affected by central immune tolerance, and have both high immunogenicity and tumor specificity, making them ideal targets for treatment and a promising direction for personalized immunotherapy. Although the research and application of immunotherapy in malignant melanoma has a long history and has achieved significant results, there are still considerable limitations. This article reviewed the types and mechanisms of tumor vaccines related to malignant melanoma and analyze the effectiveness and limitations of each type of vaccine.

malignant melanoma  /  immunotherapy  /  tumor vaccine
郭蓓, 吴飞, 强燕. 恶性黑色素瘤个体化治疗方向:肿瘤疫苗. 世界临床药物, 2025 , 46 (9) : 878 -883 . DOI: 10.13683/j.wph.2025.09.002
Bei GUO, Fei WU, Yan QIANG. A personalized treatment direction for melanoma: vaccine[J]. World Clinical Drug, 2025 , 46 (9) : 878 -883 . DOI: 10.13683/j.wph.2025.09.002

参考文献 引证文献
排序方式:
[1]
LONG GV, SWETTER SM, MENZIES AM, et al. Cutaneous melanoma[J]. Lancet, 2023, 402(10400): 485-502.
[2]
WASEH S, LEE JB. Advances in melanoma: epidemiology, diagnosis, and prognosis[J]. Front Med(Lausanne), 2023,10: 1268479.
[3]
SAXENA M, VAN DER BURG SH, MELIEF CJM, et al. Therapeutic cancer vaccines[J]. Nat Rev Cancer, 2021,21(6): 360-378.
[4]
JHUNJHUNWALA S, HAMMER C, DELAMARRE L. Antigen presentation in cancer: Insights into tumour immunogenicity and immune evasion[J]. Nat Rev Cancer, 2021, 21(5): 298-312.
[5]
RUHLAND MK, ROBERTS EW, CAI E, et al. Visualizing synaptic transfer of tumor antigens among dendritic cells[J]. Cancer Cell, 2020, 37(6): 786-799.
[6]
GILES JR, GLOBIG AM, KAECH SM, et al. CD8+ T cells in the cancer-immunity cycle[J]. Immunity, 2023, 56(10):2231-2253.
[7]
SPEISER DE, CHIJIOKE O, SCHAEUBLE K, et al. CD4+ T cells in cancer[J]. Nat Cancer, 2023, 4(3): 317-329.
[8]
KALARIYA M, GANTA S, AMIJI M. Multi-compartmental vaccine delivery system for enhanced immune response to GP100 peptide antigen in melanoma immunotherapy[J]. Pharm Res, 2012, 29(12): 3393-3403.
[9]
Al FAYEZ N, NASSAR MS, ALSHEHRI AA, et al. Recent advancement in mRNA vaccine development and applications[J]. Pharmaceutics, 2023, 15(7): 1972.
[10]
LEE KW, YAM JWP, MAO X. Dendritic cell vaccines: a shift from conventional approach to new generations[J]. Cells, 2023, 12(17): 2147.
[11]
CHI H, HAO Y, WANG X, et al. A therapeutic whole-tumor-cell vaccine covalently conjugated with a TLR7 agonist[J]. Cells, 2022, 11(13): 1986.
[12]
PENG M, MO YZ, WANG Y, et al. Neoantigen vaccine:an emerging tumor immunotherapy[J]. Mol Cancer, 2019,18(1): 128.
[13]
MAURER DM, BUTTERFIELD LH, VUJANOVIC L. Melanoma vaccines: clinical status and immune endpoints[J]. Melanoma Res, 2019, 29(2): 109-118.
[14]
SHEIKHI A, JAFARZADEH A, KOKHAEI P, et al. Whole tumor cell vaccine adjuvants: comparing IL-12 to IL-2 and IL-15[J]. Iran J Immunol, 2016, 13(3): 148-166.
[15]
KAN B, YANG L, WEN YJ, et al. Irradiated VEGF164-modified tumor cell vaccine protectedmice from the parental tumor challenge[J]. Anticancer Drugs, 2017, 28(2): 197-205.
[16]
MENG JQ, LV YL, BAO WE, et al. Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation[J]. Nat Commun, 2023, 14(1): 4505.
[17]
GUO LN, DING JS, ZHOU WH. Converting bacteria into autologous tumor vaccine via surface biomineralization of calcium carbonate for enhanced immunotherapy[J]. Acta Pharm Sin B, 2023, 13(12): 5074-5090.
[18]
REZAEI T, DAVOUDIAN E, KHALILI S, et al. Strategies in DNA vaccine for melanoma cancer[J]. Pigment Cell Melanoma Res, 2021, 34(5): 869-891.
[19]
COLLURU VT, JOHNSON LE, OLSON BM, et al. Preclinical and clinical development of DNA vaccines for prostate cancer[J]. Urol Oncol, 2016, 34(4): 193-204.
[20]
PELLIN MA. The use of oncept melanoma vaccine in veterinary patients: a review of the literature[J]. Vet Sci, 2022, 9(11): 597.
[21]
DUPERRET EK, LIU SJ, PAIK M, et al. A designer cross-reactive DNA immunotherapeutic vaccine that targets multiple MAGE-A family members simultaneously for cancer therapy[J]. Clin Cancer Res, 2018, 24(23): 6015-6027.
[22]
SAHIN U, OEHM P, DERHOVANESSIAN E, et al. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma[J]. Nature, 2020, 585(7823): 107-112.
[23]
BORDON Y. An RNA vaccine for advanced melanoma[J]. Nat Rev Drug Discov, 2020, 19(10): 671.
[24]
WEBER JS, CARLINO MS, KHATTAK A, et al. Individualised neoantigen therapy mRNA-4157(V940)plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma(KEYNOTE-942): a randomised, phase 2b study[J]. Lancet, 2024, 403(10427): 632-644.
[25]
LIU WS, TANG HC, LI LF, et al . Peptide-based therapeutic cancer vaccine: current trends in clinical application[J]. Cell Prolif, 2021, 54(5): e13025.
[26]
LI WH, SU JY, LI YM. Rational design of T-cell- and B-cell-based therapeutic cancer vaccines[J]. Acc Chem Res, 2022,55(18): 2660-2671.
[27]
ESFANDIARY A, GHAFOURI-FARD S. MAGE-A3:an immunogenic target used in clinical practice[J]. Immunotherapy, 2015, 7(6): 683-704.
[28]
SCHWARTZENTRUBER DJ, LAWSON DH, RICHARDS JM, et al. GP100 peptide vaccine and interleukin-2 in patients with advanced melanoma[J]. N Engl J Med, 2011, 364(22):2119-2127.
[29]
HODI FS, O'DAY SJ, MCDERMOTT DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma[J]. N Engl J Med, 2010, 363(8): 711-723.
[30]
ELWAKEEL A, BRIDGEWATER HE, BENNETT J. Unlocking dendritic cell-based vaccine efficacy through genetic modulation-how soon is now?[J]. Genes(Basel), 2023, 14(12): 2118.
[31]
ADAMIK J, MUNSON PV, MAURER DM, et al. Immunometabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients[J]. Nat Commun, 2023, 14(1): 7211.
[32]
FARHOOD B, NAJAFI M, MORTEZAEE K. CD8+cytotoxic T lymphocytes in cancer immunotherapy: a review[J]. J Cell Physiol, 2019, 234(6): 8509-8521.
[33]
WANG RH, ZHU TC, HOU BZ, et al. An iPSC-derived exosome-pulsed dendritic cell vaccine boosts antitumor immunity in melanoma[J]. Mol Ther, 2023, 31(8): 2376-2390.
[34]
XUE L, ZHANG HY, ZHENG XM, et al. Treatment of melanoma with dendritic cell vaccines and immune checkpoint inhibitors: a mathematical modeling study[J]. J Theor Biol, 2023, 568(19): 111489.
2025年第46卷第9期
53
13
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2025.09.002
  • 接收时间:2024-11-27
  • 首发时间:2026-11-09
  • 出版时间:2025-09-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-11-27
基金
作者信息
    a.上海同济大学附属皮肤病医院皮肤科,上海 200443
    b.上海同济大学附属皮肤病医院病理科,上海 200443

通讯作者:

吴飞,主治医师,研究方向:皮肤病理。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.09.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏